+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Interventional Cardiology Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 184 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4806454
The global market for Interventional Cardiology Devices was estimated at US$16.8 Billion in 2023 and is projected to reach US$26.4 Billion by 2030, growing at a CAGR of 6.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

How Are Technological Innovations Impacting the Interventional Cardiology Devices Market?

Technological innovations have been a major driving force in the interventional cardiology devices market, leading to the development of advanced devices that improve patient outcomes and procedural efficiency. Recent advancements in stent technology, such as the introduction of bioresorbable stents and drug-eluting stents, have significantly reduced complications associated with traditional metal stents. Furthermore, innovations in imaging technologies, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are providing clearer insights during procedures, enabling cardiologists to make more accurate decisions. The integration of robotics and artificial intelligence into interventional cardiology is also on the rise, facilitating precise and minimally invasive procedures, which reduce recovery times and enhance patient comfort. As these technologies continue to evolve, they are expected to drive further growth and transformation in the market, offering new possibilities for the diagnosis and treatment of cardiovascular diseases.

Why Is the Growing Prevalence of Cardiovascular Diseases Fueling Market Demand?

The growing prevalence of cardiovascular diseases (CVDs) is a critical factor fueling the demand for interventional cardiology devices. CVDs, including coronary artery disease, heart attacks, and stroke, remain the leading cause of mortality worldwide, driven by factors such as aging populations, unhealthy lifestyles, obesity, and smoking. The increasing burden of these diseases has led to a higher demand for minimally invasive procedures that offer quicker recovery, reduced hospital stays, and lower healthcare costs. Interventional cardiology procedures, such as angioplasty, stenting, and atherectomy, are becoming more common as they provide effective alternatives to traditional surgical methods. This rising demand for minimally invasive solutions is driving the adoption of advanced interventional cardiology devices, thereby boosting market growth.

What Role Do Emerging Markets Play in Shaping Future Growth Prospects?

Emerging markets are playing a significant role in shaping the future growth prospects of the interventional cardiology devices market. Countries in Asia-Pacific, Latin America, and the Middle East are experiencing rapid growth in healthcare infrastructure, increased healthcare spending, and improved access to medical services. Additionally, the rising prevalence of cardiovascular diseases in these regions, due to urbanization, lifestyle changes, and increased life expectancy, is creating substantial demand for advanced interventional cardiology devices. Governments in these markets are also actively investing in healthcare reforms and are focusing on enhancing the availability of specialized cardiology services. Moreover, the growing awareness about minimally invasive procedures and the presence of a large patient pool present lucrative opportunities for market players to expand their footprint and tap into these high-growth regions.

How Is the Growth in the Interventional Cardiology Devices Market Driven by Several Factors?

The growth in the interventional cardiology devices market is driven by several factors, including the increasing prevalence of cardiovascular diseases, advancements in device technology, and the expansion of healthcare infrastructure in emerging markets. The continuous development of innovative devices, such as drug-eluting stents, bioresorbable vascular scaffolds, and next-generation imaging systems, is enhancing the effectiveness and safety of interventional procedures, driving higher adoption among healthcare providers. The rising awareness and preference for minimally invasive procedures among patients are also boosting the demand for interventional cardiology devices. Additionally, the aging global population and the growing incidence of risk factors like hypertension and diabetes are further contributing to market growth. As emerging economies invest in healthcare modernization and expand access to advanced cardiology services, the market for interventional cardiology devices is set to experience robust growth in the coming years.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Angioplasty Balloons segment, which is expected to reach US$7.3 Billion by 2030 with a CAGR of a 7.2%. The Angioplasty Stents segment is also set to grow at 7.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was valued at $4.5 Billion in 2023, and China, forecasted to grow at an impressive 11.2% CAGR to reach $6.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Interventional Cardiology Devices Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Interventional Cardiology Devices Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Interventional Cardiology Devices Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 22 Featured):

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cook Medical, Inc.
  • Johnson & Johnson
  • Medtronic, Inc.
  • Smiths Medical
  • Terumo Corporation

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of COVID-19 and a Looming Global Recession
  • Interventional Cardiology Devices - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Adoption of Minimally Invasive Procedures Driving Market Growth
  • Technological Advancements in Stent Designs Enhancing Patient Outcomes
  • Rising Prevalence of Cardiovascular Diseases Boosting Demand for Cardiology Devices
  • Growing Preference for Drug-Eluting Balloons Over Traditional Stents
  • Development of Bioabsorbable Stents as a Sustainable Alternative
  • Integration of Imaging Technologies in Interventional Devices Improving Precision
  • Expanding Geriatric Population Base Leading to Higher Procedure Volumes
  • Growing Investments in R&D Leading to Innovative Device Launches
  • Surge in Demand for Hybrid Operating Rooms Enhancing Surgical Capabilities
  • Regulatory Approvals and Favorable Reimbursement Policies Driving Market Adoption
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Interventional Cardiology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Interventional Cardiology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Angioplasty Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Angioplasty Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Angioplasty Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Structural Heart Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Structural Heart Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Structural Heart Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Plaque Modification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Hemodynamic Flow Alteration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Other Device Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: USA Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: USA 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: Canada 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
JAPAN
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 32: Japan Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Japan Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Japan 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
CHINA
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 35: China Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: China Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: China 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
EUROPE
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 38: Europe Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 39: Europe Historic Review for Interventional Cardiology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: Europe 16-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 41: Europe Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: Europe Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: Europe 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
FRANCE
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 44: France Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: France Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: France 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
GERMANY
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 47: Germany Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: Germany Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Germany 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
ITALY
  • Table 50: Italy Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Italy Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Italy 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 53: UK Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: UK Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: UK 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
SPAIN
  • Table 56: Spain Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Spain Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: Spain 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
RUSSIA
  • Table 59: Russia Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: Russia Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: Russia 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 62: Rest of Europe Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Rest of Europe Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Rest of Europe 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 65: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 66: Asia-Pacific Historic Review for Interventional Cardiology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Asia-Pacific 16-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 68: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Asia-Pacific Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: Asia-Pacific 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
AUSTRALIA
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cook Medical, Inc.
  • Johnson & Johnson
  • Medtronic, Inc.
  • Smiths Medical
  • Terumo Corporation

Table Information